CD8+ T cells in Autoimmunity

Palmer, 2003, Negative selection-clearing out the bad apples from the T-cell repertoire, Nat Rev Immunol, 3, 383, 10.1038/nri1085 Zehn, 2006, T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity, Immunity, 25, 261, 10.1016/j.immuni.2006.06.009 Van Parijs, 1998, Homeostasis and self-tolerance in the immune system: turning lymphocytes off, Science, 280, 243, 10.1126/science.280.5361.243 Redmond, 2005, Peripheral tolerance of CD8 T lymphocytes, Immunity, 22, 275, 10.1016/j.immuni.2005.01.010 Dyment, 2004, An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: A report from the Canadian Collaborative Study Group, Hum Mol Genet, 13, 1005, 10.1093/hmg/ddh123 Lincoln, 2005, A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis, Nat Genet, 37, 1108, 10.1038/ng1647 Nepom, 1998, Molecular basis for HLA-DQ associations with IDDM, Diabetes, 47, 1177, 10.2337/diab.47.8.1177 Langholz, 1995, Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. DiMe Study Group. Childhood Diabetes in Finland, Genet Epidemiol, 12, 441, 10.1002/gepi.1370120502 Noble, 2002, The HLA class I A locus affects susceptibility to type 1 diabetes, Hum Immunol, 63, 657, 10.1016/S0198-8859(02)00421-4 Tait, 2003, HLA genes associated with autoimmunity and progression to disease in type 1 diabetes, Tissue Antigens, 61, 146, 10.1034/j.1399-0039.2003.00013.x Itoh, 1993, Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients, J Clin Invest, 92, 2313, 10.1172/JCI116835 Santamaria, 1992, Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes, Diabetes, 41, 53, 10.2337/diab.41.1.53 Somoza, 1994, Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile, J Immunol, 153, 1360, 10.4049/jimmunol.153.3.1360 Vizler, 1999, Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models, Immunol Rev, 169, 81, 10.1111/j.1600-065X.1999.tb01308.x Nagata, 1994, Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice, J Immunol, 152, 2042, 10.4049/jimmunol.152.4.2042 Serreze, 1995, Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent, J Immunol, 158, 3978, 10.4049/jimmunol.158.8.3978 Serreze, 1994, Major histocompatibility complex class I-deficient NODB2mnull mice are diabetes and insulitis resistant, Diabetes, 43, 505, 10.2337/diab.43.3.505 Wang, 1996, The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus, Eur J Immunol, 26, 1762, 10.1002/eji.1830260815 DiLorenzo, 1998, Major histocompatibility complex class Irestricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement, Proc Natl Acad Sci USA, 95, 12538, 10.1073/pnas.95.21.12538 Sumida, 1994, Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice, Int Immunol, 6, 1445, 10.1093/intimm/6.9.1445 Pearson, 2003, Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice, J Immunol, 171, 185, 10.4049/jimmunol.171.1.185 Christianson, 1993, Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD. NON-Thy-1a donors, Diabetes, 42, 44, 10.2337/diab.42.1.44 Wong, 1999, Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library, Nat Med, 5, 1026, 10.1038/12465 Santamaria, 1995, Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences, J Immunol, 154, 2494, 10.4049/jimmunol.154.5.2494 Verdaguer, 1996, Acceleration of spontaneous diabetes in TCRbeta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains, J Immunol, 157, 4726, 10.4049/jimmunol.157.10.4726 Lieberman, 2003, Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes, Proc Natl Acad Sci USA, 100, 8384, 10.1073/pnas.0932778100 Verdaguer, 1997, Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice, J Exp Med, 186, 1663, 10.1084/jem.186.10.1663 Trudeau, 2003, Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood, J Clin Invest, 111, 217, 10.1172/JCI200316409 Amrani, 2000, Progression of autoimmune diabetes driven by avidity maturation of a T-cell population, Nature, 406, 739, 10.1038/35021081 Han, 2005, Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes, J Clin Invest, 115, 1879, 10.1172/JCI24219 Han, 2005, Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide, Nat Med, 11, 645, 10.1038/nm1250 Standifer, 2006, Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives, Diabetes, 55, 3061, 10.2337/db06-0066 Hassainya, 2005, Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology, Diabetes, 54, 2053, 10.2337/diabetes.54.7.2053 Toma, 2005, Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients, Proc Natl Acad Sci USA, 102, 10581, 10.1073/pnas.0504230102 Pinkse, 2006, HLA class I epitope discovery in type 1 diabetes: Independent and reproducible identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee, Ann NY Acad Sci, 1079, 19, 10.1196/annals.1375.003 Serreze, 2007, “Humanized” HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes, Ann NY Acad Sci, 1103, 103, 10.1196/annals.1394.019 Takaki, 2006, HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes, J Immunol, 176, 3257, 10.4049/jimmunol.176.5.3257 Blancou, 2007, Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients, J Immunol, 178, 7458, 10.4049/jimmunol.178.11.7458 Furuzawa-Carballeda, 2007, Autoimmune inflammation from the Th17 perspective, Autoimmun Rev, 6, 169, 10.1016/j.autrev.2006.10.002 Sospedra, 2005, Immunology of multiple sclerosis, Annu Rev Immunol, 23, 683, 10.1146/annurev.immunol.23.021704.115707 Huseby, 1999, Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice, J Immunol, 163, 1115, 10.4049/jimmunol.163.3.1115 Sun, 2001, Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice, J Immunol, 166, 7579, 10.4049/jimmunol.166.12.7579 Huseby, 2001, A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis, J Exp Med, 194, 669, 10.1084/jem.194.5.669 Ford, 2005, Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis, Eur J Immunol, 35, 76, 10.1002/eji.200425660 Fogdell-Hahn, 2000, Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease, Tissue Antigens, 55, 140, 10.1034/j.1399-0039.2000.550205.x Yeo, 2007, A second major histocompatibility complex susceptibility locus for multiple sclerosis, Ann Neurol, 61, 228, 10.1002/ana.21063 van Oosten, 1997, Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, doubleblind, placebo-controlled, MR-monitored phase II trial, Neurology, 49, 351, 10.1212/WNL.49.2.351 Hauser, 1986, Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions, Ann Neurol, 19, 578, 10.1002/ana.410190610 Grenier, 1989, Immunohistochemical studies of adult human glial cells, J Neuroimmunol, 21, 103, 10.1016/0165-5728(89)90166-5 Booss, 1983, Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis, J Neurol Sci, 62, 219, 10.1016/0022-510X(83)90201-0 Jacobsen, 2002, Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients, Brain, 125, 538, 10.1093/brain/awf059 Babbe, 2000, Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction, J Exp Med, 192, 393, 10.1084/jem.192.3.393 Neumann, 2002, lymphocytes in autoimmune and degenerative CNS diseases, Trends Neurosci, 25, 313, 10.1016/S0166-2236(02)02154-9 Jurewicz, 1998, MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptidespecific CD8 T lymphocytes, J Immunol, 160, 3056, 10.4049/jimmunol.160.6.3056 Tsuchida, 1994, Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides, Proc Natl Acad Sci USA, 91, 10859, 10.1073/pnas.91.23.10859 Dressel, 1997, Autoantigen recognition by human CD8 T cell clones: Enhanced agonist response induced by altered peptide ligands, J Immunol, 159, 4943, 10.4049/jimmunol.159.10.4943 Pascolo, 1997, HLA-A2.1-restricted education and cytolytic activity of CD8+ T lymphocytes from beta2 microglobulin (‚2m) HLA-A2.1 monochain transgenic H-2Db ‚2m double knockout mice, J Exp Med, 185, 2043, 10.1084/jem.185.12.2043 Mars, 2007, CD8 T cell responses to myelin oligodendrocyte glycoproteinderived peptides in humanized HLA-A*0201-transgenic mice, J Immunol, 179, 5090, 10.4049/jimmunol.179.8.5090 de Jersey, 2007, Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice, Proc Natl Acad Sci USA, 104, 1295, 10.1073/pnas.0610057104 Gagnerault, 2002, Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice, J Exp Med, 196, 369, 10.1084/jem.20011353 Turley, 2003, Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model, J Exp Med, 198, 1527, 10.1084/jem.20030966 Yamanouchi, 2003, Cross-priming of diabetogenic T cells dissociated from CTL induced shedding of beta cell autoantigens, J Immunol, 171, 6900, 10.4049/jimmunol.171.12.6900 Trudeau, 2000, Neonatal beta-cell apoptosis: A trigger for autoimmune diabetes?, Diabetes, 49, 1, 10.2337/diabetes.49.1.1 Zhang, 2002, In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes, J Immunol, 168, 1466, 10.4049/jimmunol.168.3.1466 Kurts, 1999, CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose, Proc Natl Acad Sci USA, 96, 12703, 10.1073/pnas.96.22.12703 Harbers, 2007, Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance, J Clin Invest, 117, 1361, 10.1172/JCI29470 Rock, 2005, Cross-presentation: Underlying mechanisms and role in immune surveillance, Immunol Rev, 207, 166, 10.1111/j.0105-2896.2005.00301.x Frigerio, 2002, Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis, Nat Med, 8, 1414, 10.1038/nm1202-792 Lang, 2005, Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease, Nat Med, 11, 138, 10.1038/nm1176 Baccala, 2007, TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity, Nat Med, 13, 543, 10.1038/nm1590 Graser, 2000, Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions, J Immunol, 164, 3913, 10.4049/jimmunol.164.7.3913 Heath, 2001, Cross-presentation, dendritic cells, tolerance and immunity, Annu Rev Immunol, 19, 47, 10.1146/annurev.immunol.19.1.47 Probst, 2005, Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4, Nat Immunol, 6, 280, 10.1038/ni1165 Perez, 1997, Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement, Immunity, 6, 411, 10.1016/S1074-7613(00)80284-8 Tivol, 1995, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4, Immunity, 3, 541, 10.1016/1074-7613(95)90125-6 Waterhouse, 1995, Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4, Science, 270, 985, 10.1126/science.270.5238.985 Perrin, 1996, CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis, J. Immunol., 157, 1333, 10.4049/jimmunol.157.4.1333 Keir, 2007, PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues, J Immunol, 179, 5064, 10.4049/jimmunol.179.8.5064 Wang, 2005, Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes, Proc Natl Acad Sci USA, 102, 11823, 10.1073/pnas.0505497102 Nishimura, 1999, Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor, Immunity, 11, 141, 10.1016/S1074-7613(00)80089-8 Salama, 2003, Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis, J Exp Med, 198, 71, 10.1084/jem.20022119 Latchman, 2004, PD-L1-deficient mice show that PD-L1 on T cells, antigenpresenting cells, and host tissues negatively regulates T cells, Proc Natl Acad Sci USA, 101, 10691, 10.1073/pnas.0307252101 Keir, 2006, Tissue expression of PD-L1 mediates peripheral T cell tolerance, J Exp Med, 203, 883, 10.1084/jem.20051776 Ansari, 2003, The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice, J Exp Med, 198, 63, 10.1084/jem.20022125 Guleria, 2007, Mechanisms of PDL1-mediated regulation of autoimmune diabetes, Clin Immunol, 125, 16, 10.1016/j.clim.2007.05.013 Fife, 2006, Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway, J Exp Med, 203, 2737, 10.1084/jem.20061577 Gao, 2003, Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival, Transplantation, 76, 994, 10.1097/01.TP.0000085010.39567.FB Rodgers, 2005, MHC class Ib molecules bridge innate and acquired immunity, Nat Rev Immunol, 5, 459, 10.1038/nri1635 Hu, 2004, Analysis of regulatory CD8 T cells in Qa-1-deficient mice, Nat Immunol, 5, 516, 10.1038/ni1063 Gaur, 1993, Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness, Science, 259, 91, 10.1126/science.8418501 Jiang, 1998, T cell vaccination induces T cell receptor V‚-specific Qa-1-restricted regulatory CD8+ T cells, Proc Natl Acad Sci USA, 95, 4533, 10.1073/pnas.95.8.4533 Madakamutil, 2003, cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes, J Immunol, 170, 2985, 10.4049/jimmunol.170.6.2985 Tang, 2006, Regulation of immunity by a novel population of Qa-1-estricted CD8αα+TCRαβ+ T cells, J Immunol, 177, 7645, 10.4049/jimmunol.177.11.7645 Panoutsakopoulou, 2004, Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes, J Clin Invest, 113, 1218, 10.1172/JCI20772 Jiang, 2005, An affinity/avidity model of peripheral T cell regulation, J Clin Invest, 115, 302, 10.1172/JCI23879 Shmidt, 2003, Glatiramer acetate (Copaxone) influence on different stages of multiple sclerosis pathogenesis, Zh Nevrol Psikhiatr Im S S Korsakova, 79 Biegler, 2006, Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis, J Neuroimmunol, 180, 159, 10.1016/j.jneuroim.2006.07.015 Tennakoon, 2006, Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis, J Immunol, 176, 7119, 10.4049/jimmunol.176.11.7119 Suzuki, 1995, Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta, Science, 268, 1472, 10.1126/science.7770771 Rifa’i, 2004, Essential roles of CD8+CD122 regulatory T cells in the maintenance of T cell homeostasis, J Exp Med, 200, 1123, 10.1084/jem.20040395 Endharti, 2005, Cutting edge: CD8CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells, J Immunol, 175, 7093, 10.4049/jimmunol.175.11.7093 Saitoh, 2007, CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves’ hyperthyroidism in a murine model, Endocrinology, 148, 6040, 10.1210/en.2007-0300 Lee, 2008, Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune Encephalomyelitis, J Immunol, 180, 825, 10.4049/jimmunol.180.2.825 Ciubotariu, 1998, Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28– regulatory T cells, J Immunol, 161, 5193, 10.4049/jimmunol.161.10.5193 Colovai, 2000, Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28– T cells, Transplantation, 69, 1304, 10.1097/00007890-200004150-00016 Najafian, 2003, Regulatory functions of CD8+CD28– T cells in an autoimmune disease model, J Clin Invest, 112, 1037, 10.1172/JCI17935 Ben-David, 2007, The role of CD8+CD28 regulatory cells in suppressing myasthenia gravisassociated responses by a dual altered peptide ligand, Proc Natl Acad Sci USA, 104, 17459, 10.1073/pnas.0708577104 Paas-Rozner, 2001, The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes, Proc Natl Acad Sci USA, 98, 12642, 10.1073/pnas.221456798 Chang, 2002, Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4, Nat Immunol, 3, 237, 10.1038/ni760 Manavalan, 2004, Alloantigen specific CD8+CD28– FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity, Int Immunol, 16, 1055, 10.1093/intimm/dxh107 Singh, 2007, CD8+ T cellmediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression, J Immunol, 178, 7649, 10.4049/jimmunol.178.12.7649 Kang, 2005, Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets, J Immunol, 174, 3247, 10.4049/jimmunol.174.6.3247 Seo, 2004, 4-1BB-mediated immunotherapy of rheumatoid arthritis, Nat Med, 0, 1088, 10.1038/nm1107